Boteng Co., Ltd. (300363.SZ) announced that the company plans to use its own funds to pledge an investment of no more than 50 million yuan to participate...
Zhitong Finance App News, Boteng Co., Ltd. (300363.SZ) announced that the company plans to invest no more than 50 million yuan with its own capital to participate in the investment of Suzhou Xingze Xingyong Emerging Medical Industry Investment Fund Management Partnership (Limited Partnership) (“Xingze Phase IV Fund”) managed by Shanghai Xingze Investment Management Co., Ltd., as a limited partner, with a fund size of 15-20 billion yuan.
According to the announcement, the Xingze Phase IV Fund will mainly invest in and incubate early-stage, high-quality life science innovation enterprises, and the invested projects may have business cooperation or other synergy with the company.